Your browser doesn't support javascript.
loading
Symptomatic pharmacotherapy in ALS: data analysis from a platform-based medication management programme.
Meyer, Thomas; Kettemann, Dagmar; Maier, André; Grehl, Torsten; Weyen, Ute; Grosskreutz, Julian; Steinbach, Robert; Norden, Jenny; George, Annette; Hermann, Andreas; Guenther, René; Petri, Susanne; Schreiber-Katz, Olivia; Dorst, Johannes; Ludolph, Albert C; Walter, Bertram; Münch, Christoph; Spittel, Susanne.
Afiliação
  • Meyer T; Department of Neurology, Center for ALS and other Motor Neuron Disorders, Charité - Universitätsmedizin Berlin, Berlin, Germany thomas.meyer@charite.de.
  • Kettemann D; Ambulanzpartner Soziotechnologie APST GmbH, Berlin, Germany.
  • Maier A; Department of Neurology, Center for ALS and other Motor Neuron Disorders, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Grehl T; Department of Neurology, Center for ALS and other Motor Neuron Disorders, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Weyen U; Department of Neurology, Center for ALS and other Motor Neuron Disorders, Alfried Krupp Krankenhaus, Essen, Germany.
  • Grosskreutz J; Department of Neurology, Center for ALS and other Motor Neuron Disorders, Berufsgenossenschaftliches Universitatsklinikum Bergmannsheil, Bochum, Germany.
  • Steinbach R; Hans Berger Department of Neurology, Jena University Hospital, Jena, Germany.
  • Norden J; Hans Berger Department of Neurology, Jena University Hospital, Jena, Germany.
  • George A; Department of Neurology, Center for ALS and other Motor Neuron Disorders, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Hermann A; Department of Neurology, Center for ALS and other Motor Neuron Disorders, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Guenther R; Department of Neurology, Translational Neurodegeneration Section Albrecht Kossel, Universitätsmedizin Rostock, Rostock, Germany.
  • Petri S; Research Site Rostock/Greifswald, DZNE, German Center for Neurodegenerative Diseases, Rostock, Germany.
  • Schreiber-Katz O; Department of Neurology, Technische Universität Dresden, Dresden, Germany.
  • Dorst J; Research Site Dresden, DZNE, German Center for Neurodegenerative Diseases, Dresden, Germany.
  • Ludolph AC; Department of Neurology, Hannover Medical School, Hannover, Germany.
  • Walter B; Department of Neurology, Hannover Medical School, Hannover, Germany.
  • Münch C; Department of Neurology, University of Ulm, Ulm, Germany.
  • Spittel S; Department of Neurology, University of Ulm, Ulm, Germany.
J Neurol Neurosurg Psychiatry ; 91(7): 783-785, 2020 07.
Article em En | MEDLINE | ID: mdl-32317400
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Neuroprotetores / Riluzol / Esclerose Lateral Amiotrófica Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurol Neurosurg Psychiatry Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Neuroprotetores / Riluzol / Esclerose Lateral Amiotrófica Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurol Neurosurg Psychiatry Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha